Nephrology Medical News about hyponatremia; conivaptan

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Conivaptan: Evidence supporting its therapeutic use in hyponatremia
Core Evidence, 08/14/09

Li–Ng M et al. – This review critically assesses the evidence that support the use of conivaptan for the treatment of patients with euvolemic and hypervolemic hyponatremia. Conivaptan is effective in raising serum sodium levels in a predictable and safe fashion in euvolemic and hypervolemic hyponatremic patients. Conivaptan provides the first molecularly targeted approach for correcting hyponatremia in hospitalized patients.

<< Previous
Acute phosphate nephropathy

Next >>
A Randomized Controlled Clinical Trial Comparing the Efficacy of...

Hyponatremia in Neurosurgical Patients: Clinical Guidelines Development
Neurosurgery, 10/26/09 Relevance Score: 90%

Prevention of Hyponatremia during Maintenance Intravenous Fluid Administration: A Prospective Randomized Study of Fluid Type versus Fluid Rate
The Journal of Pediatrics, 10/13/09 Relevance Score: 88%

Hyponatremia in Heart Failure
Journal of Intensive Care Medicine, 10/26/09 Relevance Score: 85%

New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children
Pediatric Nephrology, 11/11/09 Relevance Score: 80%